$263 Million is the total value of ARMISTICE CAPITAL, LLC's 46 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARLZ | New | ARALEZ PHARMACEUTICALS INC | $8,791,000 | – | 2,664,000 | +100.0% | 3.35% | – |
| TPX | New | TEMPUR SEALY INTL INC | $7,966,000 | – | 144,000 | +100.0% | 3.03% | – |
| New | HAIN CELESTIAL GROUP INCcall | $7,463,000 | – | 150,000 | +100.0% | 2.84% | – | |
| HZNP | New | HORIZON PHARMA PLC | $6,588,000 | – | 400,000 | +100.0% | 2.51% | – |
| THC | New | TENET HEALTHCARE CORP | $6,302,000 | – | 228,000 | +100.0% | 2.40% | – |
| SNY | New | SANOFIsponsored adr | $5,775,000 | – | 138,000 | +100.0% | 2.20% | – |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $5,292,000 | – | 240,000 | +100.0% | 2.02% | – |
| New | PERNIX THERAPEUTICS HLDGS INdebt 4.250% 4/0 | $4,834,000 | – | 22,760,000 | +100.0% | 1.84% | – | |
| New | VALEANT PHARMACEUTICALS INTLcall | $4,834,000 | – | 240,000 | +100.0% | 1.84% | – | |
| BLUE | New | BLUEBIRD BIO INC | $4,156,000 | – | 96,000 | +100.0% | 1.58% | – |
| NILE | New | BLUE NILE INC | $4,052,000 | – | 148,000 | +100.0% | 1.54% | – |
| PZZA | New | PAPA JOHNS INTL INC | $3,944,000 | – | 58,000 | +100.0% | 1.50% | – |
| DFRG | New | DEL FRISCOS RESTAURANT GROUP | $3,895,000 | – | 272,000 | +100.0% | 1.48% | – |
| HABT | New | HABIT RESTAURANTS INC | $3,866,000 | – | 236,000 | +100.0% | 1.47% | – |
| FLML | New | FLAMEL TECHNOLOGIES SAsponsored adr | $3,738,000 | – | 348,003 | +100.0% | 1.42% | – |
| RH | New | RESTORATION HARDWARE HLDGS I | $3,671,000 | – | 128,000 | +100.0% | 1.40% | – |
| RRR | New | RED ROCK RESORTS INCcl a | $3,473,000 | – | 158,000 | +100.0% | 1.32% | – |
| LB | New | L BRANDS INC | $3,357,000 | – | 50,000 | +100.0% | 1.28% | – |
| TTPH | New | TETRAPHASE PHARMACEUTICALS I | $2,073,000 | – | 482,073 | +100.0% | 0.79% | – |
| QLTI | New | QLT INC | $1,556,000 | – | 1,095,455 | +100.0% | 0.59% | – |
| SCYX | New | SCYNEXIS INC | $1,515,000 | – | 698,000 | +100.0% | 0.58% | – |
| ABUS | New | ARBUTUS BIOPHARMA CORP | $1,420,000 | – | 408,000 | +100.0% | 0.54% | – |
| LPCN | New | LIPOCINE INC NEW | $1,216,000 | – | 400,000 | +100.0% | 0.46% | – |
| New | OFFICE DEPOT INCcall | $463,000 | – | 139,900 | +100.0% | 0.18% | – | |
| SNTA | New | SYNTA PHARMACEUTICALS CORP | $156,000 | – | 600,000 | +100.0% | 0.06% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.